Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

share with twitter share with LinkedIn share with facebook
03/16/2020 | 11:45am EDT

DGAP Preliminary announcement financial reports: Fresenius Medical Care AG & Co. KGaA / Preliminary announcement on the disclosure of financial statements
Fresenius Medical Care AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

16.03.2020 / 16:41
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Medical Care AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly financial report within the 1st half-year (Q1)

Language: German
Date of disclosure: May 15, 2020
Address: https://www.freseniusmedicalcare.com/de/investoren/news-publikationen/finanzberichte/

Language: English
Date of disclosure: May 15, 2020
Address: https://www.freseniusmedicalcare.com/en/investors/news-publications/financial-reports/

Report Type: Quarterly financial report within the 2nd half-year (Q3)

Language: German
Date of disclosure: November 13, 2020
Address: https://www.freseniusmedicalcare.com/de/investoren/news-publikationen/finanzberichte/

Language: English
Date of disclosure: November 13, 2020
Address: https://www.freseniusmedicalcare.com/en/investors/news-publications/financial-reports/


16.03.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

998395  16.03.2020 

fncls.ssp?fn=show_t_gif&application_id=998395&application_name=news&site_id=zonebourse
© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
02:15pFRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
10:25aFRESENIUS SE : Berenberg maintains a Buy rating
MD
09:27aFMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg reiterates its Buy rating
MD
08:58aFMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from UBS
MD
08:24aFMC FRESENIUS MEDICAL CARE AG & CO K : Warburg Research sticks Neutral
MD
08:06aFRESENIUS SE : Warburg Research remains its Buy rating
MD
08:01aFRESENIUS SE : Barclays keeps its Buy rating
MD
07:45aFRESENIUS SE : Goldman Sachs remains its Buy rating
MD
07:15aFMC FRESENIUS MEDICAL CARE AG & CO K : Kepler Cheuvreux remains its Buy rating
MD
06:59aFMC FRESENIUS MEDICAL CARE AG & CO K : Bernstein reiterates its Neutral rating
MD
More news
Financials (USD)
Sales 2020 21 506 M - -
Net income 2020 1 548 M - -
Net Debt 2020 14 274 M - -
P/E ratio 2020 14,6x
Yield 2020 1,83%
Capitalization 22 634 M 22 604 M -
EV / Sales 2020 1,72x
EV / Sales 2021 1,61x
Nbr of Employees 124 736
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 96,61 $
Last Close Price 77,29 $
Spread / Highest target 48,5%
Spread / Average Target 25,0%
Spread / Lowest Target -17,7%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors